Kirkland-Led Lilly Inks $1.3B Deal For Cardio Drug Co. Verve
By Al Barbarino · June 17, 2025, 1:16 PM EDT
Kirkland-advised Eli Lilly and Co. said Tuesday it will acquire Paul Weiss-advised Verve Therapeutics in a deal worth up to $1.3 billion, continuing its push into next-generation genetic medicines for heart...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login